Protara Therapeutics Inc. (TARA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Protara Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Protara Therapeutics Inc. (TARA) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $146M. It trades at $2.49, up 0.81% today. 3 analysts' average target of $24.00 implies +863.9% from today's price. Kronos AI's 30-day forecast is +47.5% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $24.00 |
| Low – high | $20.00 – $27.00 |
| Analysts | 3 |
| Upside to average | +863.9% |
Kronos AI 30-day forecast
| Expected close | $3.64 (+47.5%) |
| Likely range | +41.0% … +52.4% |
| As of | 2026-10-27 |
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator